Dominique Bellet
PharmD, MD, PhD
  • Chief of the Oncobiology Laboratory at Centre René Huguenin (CRH)
  • Professor of Immunology at “Faculté des Sciences Pharmaceutiques et Biologiques de Paris”
  • Has developed 16 tests for the diagnosis and follow-up of liver, bladder, thyroid, testis or placental cancers, for the screening of Down’s syndrome and for the sepsis diagnosis

Our History

May 2003: Magnisense created by Baring Vostok Capital Partners and private investors.

2003 – 2006: Technical development carried out jointly by Petr Nikitin’s team in Moscow and Bertin Technologies in France for engineering.

June 2006: Second round of financing.

November 2006: Business development teams created both in Europe and in the USA.

September 2007: New patent application filed for a multiparametric magnetic immunoassay,  MIAplex™.

February 2008: Creation of Magnisense Biological Development Laboratory in Dardilly, France.

December 2008: Third round of financing.

2008 – 2009: Several external validation studies on-going with leading human and veterinary IVD players.